This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shiohara, M. Articles by Koeffler, H. P. Search for Related Content PubMed PubMed Citation Articles by Shiohara, M. Articles by Koeffler, H. P.

24-Oxo Metabolites of Vitamin D₃ Analogues

Disassociation of Their Prominent Antileukemic Effects from Their Lack of Calcium Modulation¹

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto 390-8621, Japan [M. S., K. K., A. K.]; Division of Hematology/Oncology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, California 90048 [J. H., Y. H., H. P. K.]; and Hoffmann LaRoche Inc., Nutley, New Jersey 07110 [M. U.]

The seco-steroid hormone, 1,25-dihydroxyvitamin D₃ [1,25(OH)₂D₃] inhibits proliferation and induces differentiation of malignant cells including those of the hematopoietic system. The 24-oxo metabolite of 1,25(OH)₂D₃ also has prominent antiproliferative activities against various cancer cells. We chemically synthesized five novel 24-oxo vitamin D₃ analogues and evaluated their abilities both to inhibit clonal growth and induce differentiation of myeloid leukemia cells and to cause hypercalcemia. The 1,25-dihydroxy-16-ene-D₃ [1,25(OH)₂-16-ene-D₃] and 1,25-dihydroxy-16-ene-19-nor-D₃ [1,25(OH)₂-16-ene-19-nor-D₃] and their 24-oxo metabolites showed greater potency than 1,25(OH)₂D₃ in their abilities to inhibit clonal proliferation of HL-60, NB4, and U937 leukemic cell lines as measured by methylcellulose soft-gel assay. Their inhibition of clonal growth was irreversible as analyzed by pulse exposure studies. The synthetic analogues also had greater potency than 1,25(OH)₂D₃ to induce differentiation of HL-60 and NB4 cells as measured by generation of superoxide, nonspecific esterase production, and induction of CD11b and CD14 cell surface antigens and to increase the proportion of these cells in the G₀-G₁ phase of the cell cycle. For most assays, the 24-oxo metabolite was slightly more potent than the unmodified analogue, and 50% activity was usually found in the nanomolar range. These analogues and their 24-oxo metabolites also inhibited fresh leukemic cell clonal proliferation. Expression of p27^KIP1, a cyclin-dependent kinase inhibitor that plays an important role in blocking the cell cycle, was found by Western blot analysis to be induced by the analogues and their 24-oxo metabolites in both HL-60 and U937 cells, suggesting a possible mechanism by which these analogues inhibit leukemic growth. Notably, the calcemic activity tested by injections of 1,25-dihydroxy-16-ene-24-oxo-19-nor-D₃ in mice was at least 12-fold less than 1,25(OH)₂-16-ene-19-nor-D₃. Taken together, chemically synthesized 24-oxo metabolites of 1,25(OH)₂-16-ene-D₃ and 1,25(OH)₂-16-ene-19-nor-D₃ irreversibly inhibited proliferation and induced differentiation of acute myeloid leukemia cells with minimal toxicity; these compounds may have a role in the maintenance phase of therapy for acute myeloid leukemia.

This article has been cited by other articles:

				M. Shiohara, A. F. Gombart, Y. Sekiguchi, E. Hidaka, S. Ito, T. Yamazaki, H. P. Koeffler, and A. Komiyama Phenotypic and functional alterations of peripheral blood monocytes in neutrophil-specific granule deficiency J. Leukoc. Biol., February 1, 2004; 75(2): 190 - 197. [Abstract] [Full Text] [PDF]

				V. Vegesna, J. O'Kelly, M. Uskokovic, J. Said, N. Lemp, T. Saitoh, T. Ikezoe, L. Binderup, and H. P. Koeffler Vitamin D3 Analogs Stimulate Hair Growth in Nude Mice Endocrinology, November 1, 2002; 143(11): 4389 - 4396. [Abstract] [Full Text] [PDF]